Floating Drug Delivery Systems: An Emerging Trend for the Treatment of Peptic Ulcer

Curr Drug Deliv. 2019;16(10):874-886. doi: 10.2174/1567201816666191018163519.

Abstract

Floating drug delivery system (FDDS) is the main approach to prolonging the gastric residence time in the stomach in which the bilayer floating tablet has the main role. It is more suitable for the treatment of local infections such as peptic ulcer, gastritis, Zollinger-Ellision syndrome, indigestion, and other local infections related to the gastrointestinal tract and also used for systemic applications. FDDS provides protection for those drugs which are acid labile and have a short half-life. It also improves bioavailability, reduces drug waste, and enhances the residence time of drugs. Nowadays, various technologies are being used for the development of FDDS. Novel drug delivery systems incorporation into bilayer floating tablets have also broadened the role of FDDS. Polymers have the main role in the development of FDDS, which serve as carriers for the drug and determine the gastric retention time and drug protection. FDDS is also an easy, cheap, and more convenient method for dual drug delivery of drugs.

Keywords: Bilayer tablet; Floating Drug Delivery System (FDDS); Gastroretentive drug delivery system; gastrointestinal tract; novel drug delivery system; peptic ulcer..

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Ulcer Agents / chemistry
  • Anti-Ulcer Agents / pharmacology*
  • Drug Delivery Systems*
  • Gastrointestinal Tract / drug effects
  • Gastrointestinal Tract / metabolism
  • Humans
  • Peptic Ulcer / drug therapy*
  • Peptic Ulcer / metabolism

Substances

  • Anti-Ulcer Agents